RT @GICC_Tours: The first PK-PD modeling study to investigate complex pharmacokinetics and concentration-effect relationship of rituximab i…
The first PK-PD modeling study to investigate complex pharmacokinetics and concentration-effect relationship of rituximab in ANCA vasculitis: a gripping work from our @PATCH_research team @UnivTours @FacmedTours https://t.co/RNBVryvGF6 https://t.co/XvDJ6FY
RT @vasculitides: Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytop…
RT @vasculitides: Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytop…
RT @vasculitides: Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytop…
RT @vasculitides: Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytop…
Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ... - PubMed - NCBI https://t.co/1dkQeUhaJl
Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited. https://t.co/1T7sXcLQKJ